UF startup ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market new soft tissue visualization capabilities for its MRIdian image-guided radiation therapy (IGRT) system. The new upgradable capabilities enhance the features of MRIdian’s SmartVISION MRI (magnetic resonance imaging), including: Expanded high-definition visualization and enhanced contrast between different tissues, to … Continue reading FDA Clears Advancements for Viewray MRIdian Radiation Therapy System